{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:41:19Z","timestamp":1782603679423,"version":"3.54.5"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T00:00:00Z","timestamp":1508803200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s10620-017-4781-x","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T09:13:57Z","timestamp":1508836437000},"page":"3269-3279","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Ocular, Auricular, and Oral Manifestations of Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"62","author":[{"given":"Sean","family":"Fine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Nee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranjal","family":"Thakuria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Duff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis A.","family":"Farraye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir A.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,24]]},"reference":[{"key":"4781_CR1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nri2340","volume":"8","author":"JH Cho","year":"2008","unstructured":"Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol. 2008;8:458\u2013466.","journal-title":"Nat Rev Immunol"},{"key":"4781_CR2","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","volume":"96","author":"CN Bernstein","year":"2001","unstructured":"Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2001;96:1116\u20131122.","journal-title":"Am J Gastroenterol"},{"key":"4781_CR3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ajg.2010.343","volume":"106","author":"SR Vavricka","year":"2011","unstructured":"Vavricka SR, Brun L, Ballabeni P, Pittet V, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106:110\u2013119.","journal-title":"Am J Gastroenterol"},{"key":"4781_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1026629528233","volume":"44","author":"KM Das","year":"1999","unstructured":"Das KM. Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis. Dig Dis Sci. 1999;44:1\u201313. doi: 10.1023\/A:1026629528233 .","journal-title":"Dig Dis Sci"},{"key":"4781_CR5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00054725-199805000-00026","volume":"4","author":"M Salmi","year":"1998","unstructured":"Salmi M, Jalkanen S. Endothelial ligands and homing of mucosal leukocytes in extraintestinal manifestations of IBD. Inflamm Bowel Dis. 1998;4:149\u2013156.","journal-title":"Inflamm Bowel Dis"},{"key":"4781_CR6","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1053\/gast.2002.35396","volume":"123","author":"TR Orchard","year":"2002","unstructured":"Orchard TR, Chua CN, Ahmad T, Cheng H, et al. Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. Gastroenterology. 2002;123:714\u2013718.","journal-title":"Gastroenterology"},{"key":"4781_CR7","first-page":"356","volume":"14","author":"EA Petrelli","year":"1982","unstructured":"Petrelli EA, McKinley M, Troncale FJ. Ocular manifestations of inflammatory bowel disease. Ann Ophthalmol. 1982;14:356\u2013360.","journal-title":"Ann Ophthalmol"},{"key":"4781_CR8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004836-199607000-00009","volume":"23","author":"FT Veloso","year":"1996","unstructured":"Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol. 1996;23:29\u201334.","journal-title":"J Clin Gastroenterol"},{"key":"4781_CR9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.dld.2012.10.013","volume":"45","author":"V Cloche","year":"2013","unstructured":"Cloche V, Buisson A, Trechot F, Batta B, et al. Ocular symptoms are not predictive of ophthalmologic inflammation in inflammatory bowel disease. Dig Liver Dis. 2013;45:195\u2013199.","journal-title":"Dig Liver Dis"},{"key":"4781_CR10","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s11894-014-0402-4","volume":"16","author":"CS Manolakis","year":"2014","unstructured":"Manolakis CS, Cash BD. Health maintenance and inflammatory bowel disease. Curr Gastroenterol Rep. 2014;16:402.","journal-title":"Curr Gastroenterol Rep"},{"key":"4781_CR11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ibd.20584","volume":"15","author":"T Felekis","year":"2009","unstructured":"Felekis T, Katsanos K, Kitsanou M, Trakos N, et al. Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: a prospective single-center study. Inflamm Bowel Dis. 2009;15:29\u201334.","journal-title":"Inflamm Bowel Dis"},{"key":"4781_CR12","doi-asserted-by":"crossref","first-page":"438402","DOI":"10.1155\/2015\/438402","volume":"2015","author":"R Mady","year":"2015","unstructured":"Mady R, Grover W, Butrus S. Ocular complications of inflammatory bowel disease. ScientificWorldJournal. 2015;2015:438402.","journal-title":"ScientificWorldJournal"},{"key":"4781_CR13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00054725-200403000-00012","volume":"10","author":"R Mintz","year":"2004","unstructured":"Mintz R, Feller ER, Bahr RL, Shah SA. Ocular manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:135\u2013139.","journal-title":"Inflamm Bowel Dis"},{"key":"4781_CR14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/bjo.2008.150961","volume":"94","author":"P Doctor","year":"2010","unstructured":"Doctor P, Sultan A, Syed S, Christen W, et al. Infliximab for the treatment of refractory scleritis. Br J Ophthalmol. 2010;94:579\u2013583.","journal-title":"Br J Ophthalmol"},{"key":"4781_CR15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509\u2013516.","journal-title":"Am J Ophthalmol"},{"key":"4781_CR16","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1111\/j.1572-0241.2008.01982_12.x","volume":"103","author":"MR Ally","year":"2008","unstructured":"Ally MR, Veerappan GR, Koff JM. Treatment of recurrent Crohn\u2019s uveitis with infliximab. Am J Gastroenterol. 2008;103:2150\u20132151.","journal-title":"Am J Gastroenterol"},{"key":"4781_CR17","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/ard.2004.025882","volume":"64","author":"B Bodaghi","year":"2005","unstructured":"Bodaghi B, Bui Quoc E, Wechsler B, Tran TH, et al. Therapeutic use of infliximab in sight threatening uveitis: retrospective analysis of efficacy, safety, and limiting factors. Ann Rheum Dis. 2005;64:962\u2013964.","journal-title":"Ann Rheum Dis"},{"key":"4781_CR18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.survophthal.2011.05.003","volume":"56","author":"K Durrani","year":"2011","unstructured":"Durrani K, Zakka FR, Ahmed M, Memon M, et al. Systemic therapy with conventional and novel immunomodulatory agents for ocular inflammatory disease. Surv Ophthalmol. 2011;56:474\u2013510.","journal-title":"Surv Ophthalmol"},{"key":"4781_CR19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/09273948.2011.633205","volume":"20","author":"JN Martel","year":"2012","unstructured":"Martel JN, Esterberg E, Nagpal A, Acharya NR. Infliximab and adalimumab for uveitis. Ocul Immunol Inflamm. 2012;20:18\u201326.","journal-title":"Ocul Immunol Inflamm"},{"key":"4781_CR20","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/bjo.2006.111666","volume":"92","author":"C Prendiville","year":"2008","unstructured":"Prendiville C, O\u2019Doherty M, Moriarty P, Cassidy L. The use of infliximab in ocular inflammation. Br J Ophthalmol. 2008;92:823\u2013825.","journal-title":"Br J Ophthalmol"},{"key":"4781_CR21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/09273948.2013.863944","volume":"22","author":"A Ragam","year":"2014","unstructured":"Ragam A, Kolomeyer AM, Fang C, Xu Y, Chu DS. Treatment of chronic, noninfectious, nonnecrotizing scleritis with tumor necrosis factor alpha inhibitors. Ocul Immunol Inflamm. 2014;22:469\u2013477.","journal-title":"Ocul Immunol Inflamm"},{"key":"4781_CR22","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.ophtha.2006.04.038","volume":"113","author":"A Galor","year":"2006","unstructured":"Galor A, Perez VL, Hammel JP, Lowder CY. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. Ophthalmology. 2006;113:2317\u20132323.","journal-title":"Ophthalmology"},{"key":"4781_CR23","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archopht.123.7.903","volume":"123","author":"EB Suhler","year":"2005","unstructured":"Suhler EB, Smith JR, Wertheim MS, Lauer AK, et al. A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes. Arch Ophthalmol. 2005;123:903\u2013912.","journal-title":"Arch Ophthalmol"},{"key":"4781_CR24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/bjophthalmol-2012-302292","volume":"97","author":"EB Suhler","year":"2013","unstructured":"Suhler EB, Lowder CY, Goldstein DA, Giles T, et al. Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial. Br J Ophthalmol. 2013;97:481\u2013486.","journal-title":"Br J Ophthalmol"},{"key":"4781_CR25","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","volume":"388","author":"QD Nguyen","year":"2016","unstructured":"Nguyen QD, Merrill PT, Jaffe GJ, Dick AD, et al. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet. 2016;388:1183\u20131192.","journal-title":"Lancet"},{"key":"4781_CR26","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1509852","volume":"375","author":"GJ Jaffe","year":"2016","unstructured":"Jaffe GJ, Dick AD, Brezin AP, Nguyen QD, et al. Adalimumab in patients with active noninfectious uveitis. N Engl J Med. 2016;375:932\u2013943.","journal-title":"N Engl J Med"},{"key":"4781_CR27","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1016\/j.ophtha.2016.08.025","volume":"123","author":"M Cordero-Coma","year":"2016","unstructured":"Cordero-Coma M, Calleja-Antolin S, Garzo-Garcia I, Nunez-Garnes AM, et al. Adalimumab for treatment of noninfectious uveitis: immunogenicity and clinical relevance of measuring serum drug levels and antidrug antibodies. Ophthalmology. 2016;123:2618\u20132625.","journal-title":"Ophthalmology"},{"key":"4781_CR28","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1155\/1997\/974282","volume":"11","author":"CA Durno","year":"1997","unstructured":"Durno CA, Ehrlich R, Taylor R, Buncic JR, et al. Keeping an eye on Crohn\u2019s disease: orbital myositis as the presenting symptom. Can J Gastroenterol. 1997;11:497\u2013500.","journal-title":"Can J Gastroenterol"},{"key":"4781_CR29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-230X-13-59","volume":"13","author":"S Verma","year":"2013","unstructured":"Verma S, Kroeker KI, Fedorak RN. Adalimumab for orbital myositis in a patient with Crohn\u2019s disease who discontinued infliximab: a case report and review of the literature. BMC Gastroenterol. 2013;13:59.","journal-title":"BMC Gastroenterol"},{"key":"4781_CR30","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/0016-5085(92)90319-T","volume":"102","author":"RC Tripathi","year":"1992","unstructured":"Tripathi RC, Kirschner BS, Kipp M, Tripathi BJ, et al. Corticosteroid treatment for inflammatory bowel disease in pediatric patients increases intraocular pressure. Gastroenterology. 1992;102:1957\u20131961.","journal-title":"Gastroenterology"},{"key":"4781_CR31","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0733-8635(18)30318-8","volume":"10","author":"L Renfro","year":"1992","unstructured":"Renfro L, Snow JS. Ocular effects of topical and systemic steroids. Dermatol Clin. 1992;10:505\u2013512.","journal-title":"Dermatol Clin"},{"key":"4781_CR32","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/ibd.21180","volume":"16","author":"DB Cury","year":"2010","unstructured":"Cury DB, Moss AC. Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2010;16:1393\u20131396.","journal-title":"Inflamm Bowel Dis"},{"key":"4781_CR33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/1097-0142(197701)39:1<58::AID-CNCR2820390111>3.0.CO;2-5","volume":"39","author":"DA Margileth","year":"1977","unstructured":"Margileth DA, Poplack DG, Pizzo PA, Leventhal BG. Blindness during remission in two patients with acute lymphoblastic leukemia: a possible complication of multimodality therapy. Cancer. 1977;39:58\u201361.","journal-title":"Cancer"},{"key":"4781_CR34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/01.WNO.0000166061.73483.CE","volume":"25","author":"G Clare","year":"2005","unstructured":"Clare G, Colley S, Kennett R, Elston JS. Reversible optic neuropathy associated with low-dose methotrexate therapy. J Neuroophthalmol. 2005;25:109\u2013112.","journal-title":"J Neuroophthalmol"},{"key":"4781_CR35","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1258\/002221503321192548","volume":"117","author":"J Mathews","year":"2003","unstructured":"Mathews J, Rao S, Kumar BN. Autoimmune sensorineural hearing loss: is it still a clinical diagnosis? J Laryngol Otol. 2003;117:212\u2013214.","journal-title":"J Laryngol Otol"},{"key":"4781_CR36","first-page":"1112","volume":"22","author":"AA Banares","year":"1995","unstructured":"Banares AA, Jover JA, Fernandez-Gutierrez B, Benitez del Castillo JM, et al. Bowel inflammation in anterior uveitis and spondyloarthropathy. J Rheumatol. 1995;22:1112\u20131117.","journal-title":"J Rheumatol"},{"key":"4781_CR37","first-page":"196","volume":"20","author":"MJ Ruckenstein","year":"1991","unstructured":"Ruckenstein MJ, Harrison RV. Autoimmune inner ear disease: a review of basic mechanisms and clinical correlates. J Otolaryngol. 1991;20:196\u2013203.","journal-title":"J Otolaryngol"},{"key":"4781_CR38","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.semarthrit.2004.07.001","volume":"34","author":"SS Broughton","year":"2004","unstructured":"Broughton SS, Meyerhoff WE, Cohen SB. Immune-mediated inner ear disease: 10-year experience. Semin Arthritis Rheum. 2004;34:544\u2013548.","journal-title":"Semin Arthritis Rheum"},{"key":"4781_CR39","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.amjoto.2008.04.009","volume":"30","author":"CS Karmody","year":"2009","unstructured":"Karmody CS, Valdez TA, Desai U, Blevins NH. Sensorineural hearing loss in patients with inflammatory bowel disease. Am J Otolaryngol. 2009;30:166\u2013170.","journal-title":"Am J Otolaryngol"},{"key":"4781_CR40","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1007\/s10620-005-2964-3","volume":"50","author":"N Akbayir","year":"2005","unstructured":"Akbayir N, Calis AB, Alkim C, Sokmen HM, et al. Sensorineural hearing loss in patients with inflammatory bowel disease: a subclinical extraintestinal manifestation. Dig Dis Sci. 2005;50:1938\u20131945. doi: 10.1007\/s10620-005-2964-3 .","journal-title":"Dig Dis Sci"},{"key":"4781_CR41","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0140-6736(02)11028-2","volume":"360","author":"C Lunardi","year":"2002","unstructured":"Lunardi C, Bason C, Leandri M, Navone R, et al. Autoantibodies to inner ear and endothelial antigens in Cogan\u2019s syndrome. Lancet. 2002;360:915\u2013921.","journal-title":"Lancet"},{"key":"4781_CR42","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.autrev.2012.07.012","volume":"12","author":"A Greco","year":"2013","unstructured":"Greco A, Gallo A, Fusconi M, Magliulo G, et al. Cogan\u2019s syndrome: an autoimmune inner ear disease. Autoimmun Rev. 2013;12:396\u2013400.","journal-title":"Autoimmun Rev"},{"key":"4781_CR43","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0025-6196(12)61951-X","volume":"61","author":"RS Vollertsen","year":"1986","unstructured":"Vollertsen RS, McDonald TJ, Younge BR, Banks PM, et al. Cogan\u2019s syndrome: 18 cases and a review of the literature. Mayo Clin Proc. 1986;61:344\u2013361.","journal-title":"Mayo Clin Proc"},{"key":"4781_CR44","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/art.1780240308","volume":"24","author":"BF Haynes","year":"1981","unstructured":"Haynes BF, Pikus A, Kaiser-Kupfer M, Fauci AS. Successful treatment of sudden hearing loss in Cogan\u2019s syndrome with corticosteroids. Arthritis Rheum. 1981;24:501\u2013503.","journal-title":"Arthritis Rheum"},{"key":"4781_CR45","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/rheumatology\/keh228","volume":"43","author":"A Grasland","year":"2004","unstructured":"Grasland A, Pouchot J, Hachulla E, Bletry O, et al. Typical and atypical Cogan\u2019s syndrome: 32 cases and review of the literature. Rheumatology (Oxford). 2004;43:1007\u20131015.","journal-title":"Rheumatology (Oxford)"},{"key":"4781_CR46","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0002-9343(90)90157-9","volume":"88","author":"NB Allen","year":"1990","unstructured":"Allen NB, Cox CC, Cobo M, Kisslo J, et al. Use of immunosuppressive agents in the treatment of severe ocular and vascular manifestations of Cogan\u2019s syndrome. Am J Med. 1990;88:296\u2013301.","journal-title":"Am J Med"},{"key":"4781_CR47","first-page":"1830","volume":"23","author":"L Riente","year":"1996","unstructured":"Riente L, Taglione E, Berrettini S. Efficacy of methotrexate in Cogan\u2019s syndrome. J Rheumatol. 1996;23:1830\u20131831.","journal-title":"J Rheumatol"},{"key":"4781_CR48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00002281-199901000-00008","volume":"11","author":"EW St Clair","year":"1999","unstructured":"St Clair EW, McCallum RM. Cogan\u2019s syndrome. Curr Opin Rheumatol. 1999;11:47\u201352.","journal-title":"Curr Opin Rheumatol"},{"key":"4781_CR49","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.3899\/jrheum.080203","volume":"35","author":"R Ghadban","year":"2008","unstructured":"Ghadban R, Couret M, Zenone T. Efficacy of infliximab in Cogan\u2019s syndrome. J Rheumatol. 2008;35:2456\u20132458.","journal-title":"J Rheumatol"},{"key":"4781_CR50","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00296-007-0373-y","volume":"27","author":"Z Touma","year":"2007","unstructured":"Touma Z, Nawwar R, Hadi U, Hourani M, Arayssi T. The use of TNF-alpha blockers in Cogan\u2019s syndrome. Rheumatol Int. 2007;27:995\u2013996.","journal-title":"Rheumatol Int"},{"key":"4781_CR51","first-page":"41","volume":"7","author":"MC Santos Sousa Dos","year":"2014","unstructured":"Dos Santos Sousa MC, Lima Lemos EF, Oliveira De Morais O, Silva Leite Coutinho AS, Martins GC. Pyoderma gangrenosum leading to bilateral involvement of ears. J Clin Aesthet Dermatol. 2014;7:41\u201343.","journal-title":"J Clin Aesthet Dermatol"},{"key":"4781_CR52","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00004836-198910000-00014","volume":"11","author":"J Lysy","year":"1989","unstructured":"Lysy J, Zimmerman J, Ackerman Z, Reifen E. Atypical auricular pyoderma gangrenosum simulating fungal infection. J Clin Gastroenterol. 1989;11:561\u2013564.","journal-title":"J Clin Gastroenterol"},{"key":"4781_CR53","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1023\/B:DDAS.0000042245.20042.4f","volume":"49","author":"MS Sapienza","year":"2004","unstructured":"Sapienza MS, Cohen S, Dimarino AJ. Treatment of pyoderma gangrenosum with infliximab in Crohn\u2019s disease. Dig Dis Sci. 2004;49:1454\u20131457. doi: 10.1023\/B:DDAS.0000042245.20042.4f .","journal-title":"Dig Dis Sci"},{"key":"4781_CR54","first-page":"930","volume":"137","author":"MH Tan","year":"2001","unstructured":"Tan MH, Gordon M, Lebwohl O, George J, Lebwohl MG. Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody. Arch Dermatol. 2001;137:930\u2013933.","journal-title":"Arch Dermatol"},{"key":"4781_CR55","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0196-0709(96)90079-4","volume":"17","author":"DJ Touma","year":"1996","unstructured":"Touma DJ, Gross EJ, Karmody CS, Fawaz KA. Relapsing polychondritis in association with Crohn\u2019s disease. Am J Otolaryngol. 1996;17:424\u2013426.","journal-title":"Am J Otolaryngol"},{"key":"4781_CR56","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/art.1780370319","volume":"37","author":"AM Asuncion","year":"1994","unstructured":"Asuncion AM, Federman DG, Kirsner RS. Swelling of the ear in a patient with ulcerative colitis. Arthritis Rheum. 1994;37:432\u2013434.","journal-title":"Arthritis Rheum"},{"key":"4781_CR57","first-page":"581","volume":"40","author":"E Michailidou","year":"2009","unstructured":"Michailidou E, Arvanitidou S, Lombardi T, Kolokotronis A, et al. Oral lesions leading to the diagnosis of Crohn disease: report on 5 patients. Quintessence Int. 2009;40:581\u2013588.","journal-title":"Quintessence Int"},{"key":"4781_CR58","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1067\/mpd.2001.113008","volume":"138","author":"S Pittock","year":"2001","unstructured":"Pittock S, Drumm B, Fleming P, McDermott M, et al. The oral cavity in Crohn\u2019s disease. J Pediatr. 2001;138:767\u2013771.","journal-title":"J Pediatr"},{"key":"4781_CR59","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ibd.20983","volume":"16","author":"M Rowland","year":"2010","unstructured":"Rowland M, Fleming P, Bourke B. Looking in the mouth for Crohn\u2019s disease. Inflamm Bowel Dis. 2010;16:332\u2013337.","journal-title":"Inflamm Bowel Dis"},{"key":"4781_CR60","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/archderm.135.4.439","volume":"135","author":"A Dupuy","year":"1999","unstructured":"Dupuy A, Cosnes J, Revuz J, Delchier JC, et al. Oral Crohn disease: clinical characteristics and long-term follow-up of 9 cases. Arch Dermatol. 1999;135:439\u2013442.","journal-title":"Arch Dermatol"},{"key":"4781_CR61","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004836-199102000-00008","volume":"13","author":"M Plauth","year":"1991","unstructured":"Plauth M, Jenss H, Meyle J. Oral manifestations of Crohn\u2019s disease. An analysis of 79 cases. J Clin Gastroenterol. 1991;13:29\u201337.","journal-title":"J Clin Gastroenterol"},{"key":"4781_CR62","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cden.2004.07.012","volume":"49","author":"F Alawi","year":"2005","unstructured":"Alawi F. Granulomatous diseases of the oral tissues: differential diagnosis and update. Dent Clin North Am. 2005;49:203\u2013221.","journal-title":"Dent Clin North Am"},{"key":"4781_CR63","first-page":"198","volume":"12","author":"G Litsas","year":"2011","unstructured":"Litsas G. Crohn\u2019s disease of the mouth: report of a case. Eur J Paediatr Dent. 2011;12:198\u2013200.","journal-title":"Eur J Paediatr Dent"},{"key":"4781_CR64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.crohns.2011.07.001","volume":"6","author":"AP Zbar","year":"2012","unstructured":"Zbar AP, Ben-Horin S, Beer-Gabel M, Eliakim R. Oral Crohn\u2019s disease: is it a separable disease from orofacial granulomatosis? A review. J Crohns Colitis. 2012;6:135\u2013142.","journal-title":"J Crohns Colitis"},{"key":"4781_CR65","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1468-3083.2009.03304.x","volume":"24","author":"SV Lourenco","year":"2010","unstructured":"Lourenco SV, Hussein TP, Bologna SB, Sipahi AM, Nico MM. Oral manifestations of inflammatory bowel disease: a review based on the observation of six cases. J Eur Acad Dermatol Venereol. 2010;24:204\u2013207.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4781_CR66","doi-asserted-by":"crossref","first-page":"8571","DOI":"10.3748\/wjg.v19.i46.8571","volume":"19","author":"KB Lankarani","year":"2013","unstructured":"Lankarani KB, Sivandzadeh GR, Hassanpour S. Oral manifestation in inflammatory bowel disease: a review. World J Gastroenterol. 2013;19:8571\u20138579.","journal-title":"World J Gastroenterol"},{"key":"4781_CR67","doi-asserted-by":"crossref","first-page":"211 e1-33","DOI":"10.1016\/j.jaad.2012.10.036","volume":"68","author":"B Thrash","year":"2013","unstructured":"Thrash B, Patel M, Shah KR, Boland CR, Menter A. Cutaneous manifestations of gastrointestinal disease: part II. J Am Acad Dermatol. 2013;68:211 e1-33.","journal-title":"J Am Acad Dermatol"},{"key":"4781_CR68","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1600-0714.2007.00589.x","volume":"36","author":"MJ McCullough","year":"2007","unstructured":"McCullough MJ, Abdel-Hafeth S, Scully C. Recurrent aphthous stomatitis revisited; clinical features, associations, and new association with infant feeding practices? J Oral Pathol Med. 2007;36:615\u2013620.","journal-title":"J Oral Pathol Med"},{"key":"4781_CR69","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1468-3083.2011.04041.x","volume":"26","author":"ID O\u2019Neill","year":"2012","unstructured":"O\u2019Neill ID. Efficacy of tumour necrosis factor-alpha antagonists in aphthous ulceration: review of published individual patient data. J Eur Acad Dermatol Venereol. 2012;26:231\u2013235.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4781_CR70","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ad.2012.02.005","volume":"103","author":"ML Martinez Martinez","year":"2012","unstructured":"Martinez Martinez ML, Azana-Defez JM, Perez-Garcia LJ, Lopez-Villaescusa MT, et al. Granulomatous cheilitis: a report of 6 cases and a review of the literature. Actas Dermosifiliogr. 2012;103:718\u2013724.","journal-title":"Actas Dermosifiliogr"},{"key":"4781_CR71","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s00415-012-6603-6","volume":"260","author":"MK Elias","year":"2013","unstructured":"Elias MK, Mateen FJ, Weiler CR. The Melkersson\u2013Rosenthal syndrome: a retrospective study of biopsied cases. J Neurol. 2013;260:138\u2013143.","journal-title":"J Neurol"},{"key":"4781_CR72","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/BF01300298","volume":"37","author":"T Bozkurt","year":"1992","unstructured":"Bozkurt T, Langer M, Fendel K, Lux G. Granulomatous tonsillitis. A rare extraintestinal manifestation of Crohn\u2019s disease. Dig Dis Sci. 1992;37:1127\u20131130. doi: 10.1007\/BF01300298 .","journal-title":"Dig Dis Sci"},{"key":"4781_CR73","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.crohns.2011.05.010","volume":"5","author":"TS Hansen","year":"2011","unstructured":"Hansen TS, Jess T, Vind I, Elkjaer M, et al. Environmental factors in inflammatory bowel disease: a case-control study based on a Danish inception cohort. J Crohns Colitis. 2011;5:577\u2013584.","journal-title":"J Crohns Colitis"},{"key":"4781_CR74","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/00042737-199612000-00010","volume":"8","author":"J Mate-Jimenez","year":"1996","unstructured":"Mate-Jimenez J, Correa-Estan JA, Perez-Miranda M, Gomez-Cedenilla A, et al. Tonsillectomy and inflammatory bowel disease location. Eur J Gastroenterol Hepatol. 1996;8:1185\u20131188.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4781_CR75","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00005537-200003000-00028","volume":"110","author":"DE Kardon","year":"2000","unstructured":"Kardon DE, Thompson LD. A clinicopathologic series of 22 cases of tonsillar granulomas. Laryngoscope. 2000;110:476\u2013481.","journal-title":"Laryngoscope"},{"key":"4781_CR76","first-page":"E114","volume":"14","author":"F Femiano","year":"2009","unstructured":"Femiano F, Lanza A, Buonaiuto C, Perillo L, et al. Pyostomatitis vegetans: a review of the literature. Med Oral Patol Oral Cir Bucal. 2009;14:E114\u2013E117.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"4781_CR77","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0030-4220(93)90097-N","volume":"75","author":"G Ficarra","year":"1993","unstructured":"Ficarra G, Cicchi P, Amorosi A, Piluso S. Oral Crohn\u2019s disease and pyostomatitis vegetans. An unusual association. Oral Surg Oral Med Oral Pathol. 1993;75:220\u2013224.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"4781_CR78","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0030-4220(94)90063-9","volume":"78","author":"CM Healy","year":"1994","unstructured":"Healy CM, Farthing PM, Williams DM, Thornhill MH. Pyostomatitis vegetans and associated systemic disease. A review and two case reports. Oral Surg Oral Med Oral Pathol. 1994;78:323\u2013328.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"4781_CR79","first-page":"279","volume":"34","author":"B Mijandrusic-Sincic","year":"2010","unstructured":"Mijandrusic-Sincic B, Licul V, Gorup L, Brncic N, et al. Pyostomatitis vegetans associated with inflammatory bowel disease\u2013report of two cases. Coll Antropol. 2010;34:279\u2013282.","journal-title":"Coll Antropol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-017-4781-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-017-4781-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-017-4781-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T02:28:40Z","timestamp":1570242520000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-017-4781-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,24]]},"references-count":79,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["4781"],"URL":"https:\/\/doi.org\/10.1007\/s10620-017-4781-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,24]]}}}